Treatment of Neuromyelitis Optica: Review and Recommendations.
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...
主要な著者: | Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, de Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2012
|
類似資料
-
Treatment of neuromyelitis optica: Review and recommendations
著者:: Kimbrough, D, 等
出版事項: (2012) -
Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
著者:: Pittock, S, 等
出版事項: (2019) -
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
著者:: Collongues, N, 等
出版事項: (2013) -
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
著者:: Mealy, M, 等
出版事項: (2014) -
Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
著者:: Fujihara, K, 等
出版事項: (2014)